Advertisement
Cleveland Clinic program to streamline clinical care and research
Infliximab-abda offers similar benefits at lower costs
Prevalence, characteristics and disease course
How rates of colectomy and biologics use have changed over time
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Post hoc analysis of phase 3 trial shows benefit
On the purpose, process and results
Action items for managing these complex patients
Yet insurance restricts its utility
Lower cost option increases access to therapies
Newer noninvasive tests allow many patients to avoid liver biopsy
Advertisement
Advertisement